Joanna Markowicz
6 Powstancow Warszawy Ave
Rzeszow, PK 35959, Poland
Rzeszow, PK 35959, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms.
Journal: International journal of molecular sciences
Published: October 25, 2021
Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 05, 2020
Alvaxanthone, a Thymidylate Synthase Inhibitor with Nematocidal and Tumoricidal Activities.
Journal: Molecules (Basel, Switzerland)
Published: May 03, 2020
The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
Journal: Molecules (Basel, Switzerland)
Published: October 01, 2019
Antitumor and anti-nematode activities of α-mangostin.
Journal: European journal of pharmacology
Published: July 03, 2019
Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 08, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026